May 19, 2024 Brendan O’Grady Dear Brendan:Non-Solicitation Agreement • August 7th, 2024 • Assertio Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 7th, 2024 Company Industry JurisdictionThis is a full-time position. While you render services to the Company, you will not engage in any other employment, consulting or other business activity (whether full-time or part-time, “Other Commitments”) that would interfere with your full-time obligation to the Company or otherwise create a conflict of interest with the Company, provided, however, that you are permitted to maintain the one external board seat that you currently hold (or one similar replacement external board seat to be reviewed with the Board in advance), in each case as long as it also does not create a conflict of interest. By signing this letter agreement, you confirm to the Company that you have disclosed in writing to the Company all current or expected future Other Commitments, and you have no contractual commitments or other legal obligations that would prohibit you from performing your duties for the Company, or otherwise conflict with such duties.
ASSERTIO HOLDINGS, INC MANAGEMENT CONTINUITY AGREEMENTManagement Continuity Agreement • August 7th, 2024 • Assertio Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 7th, 2024 Company Industry JurisdictionThis Management Continuity Agreement (the “Agreement”) is effective as of May 29, 2024 (the “Effective Date”) by and between Brendan O’Grady (“Employee”) and Assertio Holdings, Inc., a Delaware corporation (the “Company”). This Agreement is intended to provide Employee with certain benefits described herein upon the occurrence of specific events.